Publications by authors named "L Damstrup"

Claim this Profile
P
PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer.
Susy Shim, Anke Reinacher-Schick, Anna-Lena Kraeft, Per Pfeiffer, Line Schmidt Tarpgaard, Lars Damstrup

Invest New Drugs· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Yungan Tao, Xu-Shan Sun, Yoann Pointreau, Christophe Le Tourneau, Christian Sire, Lars Damstrup

Eur J Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours.
Mark T J van Bussel, Ahmad Awada, Maja J A de Jonge, Morten Mau-Sørensen, Dorte Nielsen, Lars Damstrup

Br J Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours.
Alison M Schram, Leena Gandhi, Monica M Mita, Lars Damstrup, Frank Campana

Br J Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development of new drug-radiotherapy combinations.
Ricky A Sharma, Ruth Plummer, Julie K Stock, Tessa A Greenhalgh, Ozlem Ataman, Lars Damstrup

Nat Rev Clin Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis